Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$145,000.00

DNA Nanostructures: From Design to Biological Applications

FY 2024-25

Summary
Our research during the last 6 years has led to several discoveries in the fields of supramolecular chemistry and DNA nanotechnology. These include: (a) the creation of DNA cages and nanotubes with precise control over size, shape, and molecule presentation using a minimal set of component strands. These can encapsulate therapeutics and release them when they detect a cancer-specific molecule; (b) the observation that DNA nanostructures can act as a "printing press", transferring their DNA strand patterns to gold particles, polymers, peptides, and small molecules with high fidelity; (c) a new method to reprogram DNA assembly into new structures, by simply adding a small molecule, giving DNA hydrogels with record-breaking stiffness for drug delivery and tissue engineering. (d) a new class of monodisperse and sequence-controlled macromolecules that enhance the efficacy of nucleic acid therapeutics and deliver drugs that re-sensitize patient leukemia cells to chemotherapy. (e) the construction of complex DNA structures by controlling the order of addition of their components, achieving complexity through temporal control. This proposal describes the use of DNA supramolecular chemistry to bring unprecedented structural definition to three research areas: targeted drug delivery, polymer self-assembly and biomolecule recognition. DNA cages for selective cancer targeting. In this proposal, we will develop DNA nanostructures that precisely target cancer cells, by binding to specific proteins they overexpress. Unlike traditional drug delivery nanoparticles that face selectivity issues because of heterogeneous ligand arrangement on their surface, our DNA structures can accurately position targeting molecules, offering a potential breakthrough in drug delivery precision. We will create DNA nanostructure libraries, each with a particular ligand positioning, to develop an understanding of disease protein arrangement on cells and access vehicles that selectively deliver drugs to cancer cells. Molecular "printing" on polymers with DNA. We will describe the use of DNA structures as a "printing press" to covalently transfer DNA patterns to polymers. This will result in unique polymer nanoparticles that assemble directionally, the way atoms come together to make molecules, dramatically increasing the level of control and programmability in polymer self-assembly. Biomolecule recognition with sequence-defined macromolecules. We will develop sequence-defined macromolecules as highly functional aptamers. Aptamers are antibody mimics made from nucleic acids, but they lack diversity in their functional groups. This method labels each sequence-defined macromolecule with a specific DNA barcode, allowing its identification by DNA sequencing. DNA-encoded libraries augment aptamers with a highly diverse chemical space, making them much closer to antibodies while preserving stability, ease of synthesis and discovery.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2024-06784
Name nom
Sleiman, Hanadi
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
145000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
DNA Nanostructures: From Design to Biological Applications
Keywords
supramolecular chemistry; dna chemistry; polymer chemistry; dna nanostructures; aptamers; protein mimics; stimuli-responsive materials; hydrogels; cargo encapsulation and release; orthogonal supramolecular interactions
Application summary
Our research during the last 6 years has led to several discoveries in the fields of supramolecular chemistry and DNA nanotechnology. These include: (a) the creation of DNA cages and nanotubes with precise control over size, shape, and molecule presentation using a minimal set of component strands. These can encapsulate therapeutics and release them when they detect a cancer-specific molecule; (b) the observation that DNA nanostructures can act as a "printing press", transferring their DNA strand patterns to gold particles, polymers, peptides, and small molecules with high fidelity; (c) a new method to reprogram DNA assembly into new structures, by simply adding a small molecule, giving DNA hydrogels with record-breaking stiffness for drug delivery and tissue engineering. (d) a new class of monodisperse and sequence-controlled macromolecules that enhance the efficacy of nucleic acid therapeutics and deliver drugs that re-sensitize patient leukemia cells to chemotherapy. (e) the construction of complex DNA structures by controlling the order of addition of their components, achieving complexity through temporal control. This proposal describes the use of DNA supramolecular chemistry to bring unprecedented structural definition to three research areas: targeted drug delivery, polymer self-assembly and biomolecule recognition. DNA cages for selective cancer targeting. In this proposal, we will develop DNA nanostructures that precisely target cancer cells, by binding to specific proteins they overexpress. Unlike traditional drug delivery nanoparticles that face selectivity issues because of heterogeneous ligand arrangement on their surface, our DNA structures can accurately position targeting molecules, offering a potential breakthrough in drug delivery precision. We will create DNA nanostructure libraries, each with a particular ligand positioning, to develop an understanding of disease protein arrangement on cells and access vehicles that selectively deliver drugs to cancer cells. Molecular "printing" on polymers with DNA. We will describe the use of DNA structures as a "printing press" to covalently transfer DNA patterns to polymers. This will result in unique polymer nanoparticles that assemble directionally, the way atoms come together to make molecules, dramatically increasing the level of control and programmability in polymer self-assembly. Biomolecule recognition with sequence-defined macromolecules. We will develop sequence-defined macromolecules as highly functional aptamers. Aptamers are antibody mimics made from nucleic acids, but they lack diversity in their functional groups. This method labels each sequence-defined macromolecule with a specific DNA barcode, allowing its identification by DNA sequencing. DNA-encoded libraries augment aptamers with a highly diverse chemical space, making them much closer to antibodies while preserving stability, ease of synthesis and discovery.
McGill University - $145,000 Grant (2024-25) | Canada Spends